Acute lymphoblastic leukemia (ALL) is a heterogeneous group of diseases characterized by clonal proliferation of lymphoid progenitors (lymphoblasts). Improved diagnostic tools permit accurate and prompt diagnosis and aid in evaluation of minimal residual disease (MRD). There have been significant advances…
Acute lymphoblastic leukemia (ALL) is a heterogeneous group of diseases characterized by clonal proliferation of lymphoid progenitors (lymphoblasts). Improved diagnostic tools permit accurate and prompt diagnosis and aid in evaluation of minimal residual disease (MRD). There have been significant advances…
Introduction Acute lymphoblastic leukemia (ALL) is a heterogeneous group of hematologic malignancies with an annual age-adjusted incidence rate of 1.8 per 100,000 people in the United States, with an estimated 5690 new cases and 1580 deaths according to the most…